First FDA-Approved Prostate Cancer Treatment Vaccine
First FDA-Approved Prostate Cancer Treatment Vaccine Available At Roswell Park The nation’s first FDA-approved cancer treatment vaccine, Provenge (sipuleucel-T), is being offered for the first time in Western New York at Roswell Park Cancer Institute (RPCI). The vaccine is designed for men with advanced prostate cancer who have limited treatment... more
Prostate Cancer Treatment Decisions
In Prostate Cancer Treatment Decisions, Age Plays Too Big A Role Older men with high-risk prostate cancer frequently are offered fewer – and less effective – choices of treatment than younger men, potentially resulting in earlier deaths, according to a new UCSF study. The scientists found that men above age 75 with high-risk prostate cancer... more
Prostate Cancer – What Every Man Needs to Know
Prostate cancer is one of the most common types of cancers in men. Prostate cancer is often found in elder men and the risk of prostate cancer increases with age. It occurs mostly among the male population of 50 years and above. In prostate cancer, cancerous cells are primary formed in the prostate that then gets transferred to other cells through the... more
Taking control of post-prostate cancer issues
Prostate cancer affects more than 185,000 men in the United States each year, according to the American Cancer Society. About one in six men will be diagnosed with prostate cancer during their lifetime, making it the most common cancer, other than skin cancers, in American men. The good news is that, if detected early, prostate cancer is often treatable.... more
